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Abstract Human uncoupling protein 3 (UCP3) has two RNA
transcripts that arise from the differential processing of the same
gene product. One encodes the full length protein (UCP3L) while
the other encodes a truncated version (UCP3S) lacking the sixth
membrane spanning domain. The roles of the two isoforms are
not known, but a mutation that decreases the proportion of
UCP3L decreases fat oxidation and increases susceptibility to
obesity. In the ADP/ATP carrier, a protein closely related to
UCP3, the sixth membrane spanning domain is required for
insertion into the inner membrane. Therefore, defective mem-
brane insertion of UCP3S may account for the different effects
of the two isoforms in vivo. We investigated mitochondrial import
of the two UCP3 isoforms. When epitope-tagged versions of
UCP3S and UCP3L were expressed in COS7 cells, both were
inserted into the mitochondrial inner membrane. Translation in
vitro followed by incubation with isolated mitochondria showed
that both isoforms were inserted into the inner membrane,
however, the insertion of UCP3S was significantly slower.
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1. Introduction
The ¢rst uncoupling protein (UCP1) was discovered in the
inner membrane of brown adipose tissue mitochondria, where
it dissipates the mitochondrial proton electrochemical gra-
dient as heat [1,2]. Since then, three additional human UCPs
have been discovered through their sequence homologies to
UCP1 [2,3] : UCP2 is expressed ubiquitously, UCP3 is ex-
pressed mainly in skeletal muscle and UCP4 is expressed in
the brain [2,3]. These UCPs are all members of the mitochon-
drial carrier family [4], have a molecular mass of 30^35 kDa
and contain six membrane spanning helices [1,2]. Homology
with UCP1 suggests that the other UCPs function by increas-
ing the proton leak through the inner membrane [1,2].
UCP3 was discovered in human skeletal muscle and is ex-
pressed there in large amounts [5,6]. As skeletal muscle is
important for adaptive thermogenesis, UCP3 is an attractive
candidate protein for this process [2]. Interestingly, two UCP3
mRNAs are present in vivo, the full length transcript UCP3L
and a shorter form, UCP3S, which arises from a cleavage and
polyadenylation signal located in the last intron that prema-
turely terminates about half of the transcripts [7]. UCP3L
encodes a 312 amino acid (aa) protein while UCP3S encodes
a 275 aa protein lacking the sixth transmembrane spanning
domain [5,7]. The transcript levels for UCP3L and UCP3S
were similar in a range of obese and lean subjects [5,7,8].
When UCP3 was studied as a candidate gene for patholog-
ical obesity in humans, a mutation in the splice donor site of
the sixth exon was found that results in a truncated protein
the same size as UCP3S [9]. Subjects heterozygous for this
mutation had lower rates of fat oxidation and an increased
tendency to obesity, suggesting that UCP3L favours mito-
chondrial uncoupling and fat oxidation while UCP3S does
not [9]. How this occurs is not known, but as the two
UCP3 isoforms uncouple mitochondria to similar extents
[10^12], it is unlikely to arise from an intrinsic di¡erence in
proton conductance.
UCPs are imported into mitochondria and inserted into the
inner membrane by an import machinery specialised for mem-
brane proteins [13^16]. Mitochondrial targeting information
for import by this pathway is present in the mature protein,
rather than in an N-terminal signal sequence that is removed
after import [13]. The sixth membrane spanning domain of the
ADP/ATP carrier, a protein closely related to UCP3, is re-
quired for its membrane potential dependent insertion into the
mitochondrial inner membrane [17]. As this domain is missing
from UCP3S, there may be signi¢cant di¡erences in the mi-
tochondrial insertion of the two UCP3 isoforms. To investi-
gate this hypothesis, we constructed haemagglutinin (HA)-
tagged versions of UCP3L and UCP3S and expressed them
in COS7 cells. Both isoforms were inserted into the mitochon-
drial inner membrane within cells, dissipating the membrane
potential to a similar extent. We then translated the two
UCP3 isoforms in vitro and showed that both were inserted
into the mitochondrial inner membrane in isolated yeast and
rat liver mitochondria, but that insertion was signi¢cantly
slower for UCP3S.
2. Materials and methods
2.1. Cloning and in vitro transcription and translation of UCP3L and
UCP3S
Human skeletal poly(A) RNA (Clonetech) was reverse-transcribed
using oligo d(T) and the UCP3L and UCP3S cDNAs were ampli¢ed
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 1 6 8 8 - 9
*Corresponding author. Fax: (64)-3-479 7866.
E-mail: murphy@sanger.otago.ac.nz
Abbreviations: DMEM, Dulbecco’s modi¢ed Eagle medium; FCCP,
carbonyl cyanide-p-tri£uoromethoxyphenylhydrazone; FITC, £uores-
cein isothiocyanate; HA, haemagglutinin; TPMP, methyltriphenyl-
phosphonium; UCP, uncoupling protein; UCP3L, full length iso-
form; UCP3S, truncated isoform
FEBS 23116 30-12-99 Cyaan Magenta Geel Zwart
FEBS 23116 FEBS Letters 465 (2000) 135^140
using the same 5P primer (CTT CCA GGA CTA TGG TGG) but
di¡erent 3P primers (GTT CAA AAC GGT GAT TCC CG for
UCP3L and GAAAGAAGCCCCTGTTCTCTG for UCP3S [5]).
The PCR products were subcloned into pYES2 and sequenced. Com-
parison with the GenBank sequences (U82818 for UCP3S; U84763
for UCP3L) showed one silent C to T transition at nucleotide 783 in
UCP3S and two silent transitions: a T to C at nucleotide 450 and a C
to T at nucleotide 783. Linearised pYES2 plasmids were transcribed
using T7 polymerase and translated in vitro in the presence of
[35S]methionine in a rabbit reticulocyte lysate [18]. Electrophoresis
on a 16% Tris^Tricine gel [19] followed by £uorography gave single
products of the expected molecular weights for UCP3S and UCP3L
(29.7 kDa and 34.1 kDa, respectively).
2.2. Construction of HA-tagged UCP3L and UCP3S
HA-tagged UCP3S and UCP3L were constructed by adding 12 aa
HA tags (CYPYDVPDYASL) to their C-termini. Plasmids containing
UCP3L or UCP3S were PCR-ampli¢ed using Expand Hi Fidelity
polymerase, a 5P primer incorporating a HindIII site before the start
codon and 3P primers encoding the HA tag and incorporating an
EcoRI site after the stop codon. The 5P primer was GGGGAAGCT-
TATGGTTGGACTGAAGCCTTCA and the 3P primers were
GGGGGAATTCTCATAGGGAAGCGTAGTCAGGCACATCAT-
ATGGATAGCAAAACGGTGATTCCCGTAA and GGGGGAA-
TTCTCATAGGGAAGCGTAGTCAGGCACATCATATGGATAG-
CACCCCTTGTAGAAGGCTGT for UCP3L-HA and UCP3S-HA,
respectively. After digestion with HindIII and EcoRI, the PCR prod-
ucts were gel-puri¢ed, ligated into pcDNA3 (Invitrogen) and trans-
formed into Escherichia coli. Clones were selected by restriction diges-
tion of plasmids and by PCR, and then con¢rmed by complete DNA
sequencing of the plasmid insert. Plasmids linearised with XhoI were
transcribed using T7 polymerase and translated in a rabbit reticulo-
cyte lysate in the presence of [35S]methionine. This gave single prod-
ucts of the correct sizes (31.1 kDa for UCP3S-HA and 35.6 kDa for
UCP3L-HA) by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE)/£uorography.
2.3. Expression of UCP3L-HA and UCP3S-HA in COS cells
COS7 cells were grown at 37‡C in Dulbecco’s modi¢ed Eagle me-
dium (DMEM) supplemented with 10 U/ml penicillin, 100 mg/ml
streptomycin sulfate and 10% foetal calf serum under 95% air/5%
CO2, then transiently transfected using lipofectin (Life Technologies,
Gaithersburg, MD, USA). After 10^15 h at 37‡C, the transfection
medium was replaced with serum-containing DMEM and cells were
harvested after further incubation. For immunohistochemistry, cells
grown on glass coverslips were transfected, then Mitotracker (1 WM;
Molecular Probes) was added to the incubation medium and incu-
bated at 37‡C for 30 min. After ¢xation with 3% paraformaldehyde
in phosphate-bu¡ered saline (PBS), cells were incubated with 50 mM
NH4Cl in PBS, permeabilised with 0.1% Triton X-100 in PBS and
non-speci¢c binding was blocked with 1% bovine serum albumin
(BSA) in PBS. A mouse monoclonal antibody against the HA tag
(12CA5, Babco, Richmond, CA, USA; 1:200 in BSA/PBS) was added
for 1^2 h and then incubated with £uorescein isothiocyanate (FITC)-
conjugated rabbit anti-mouse IgG (Organon Teknika-Cappel; 1:200
in BSA/PBS) for 30 min. Coverslips were then mounted in Mowiol
(Hoechst Pharmaceuticals) and analysed using an Axiomat BSTV
confocal microscope and images were processed using Datavision
and Photoshop.
2.4. Preparation and analysis of mitochondria from COS cells
Cells were transiently transfected with UCP3S-HA or UCP3L-HA,
harvested by treatment with trypsin/EDTA and washed in cold PBS
supplemented with protease inhibitors (1.25 Wg/ml leupeptin, 0.75 Wg/
ml antipain, 0.25 Wg/ml chymostatin, 0.25 Wg/ml elastinol, 5 Wg/ml
pepstatin). Cells were then washed in STE (250 mM sucrose, 10
mM Tris^HCl, pH 7.4, 1 mM EGTA), suspended in 1^2 ml STE
supplemented with protease inhibitors on ice for 20 min and then
homogenised in a 2 ml glass homogeniser [20]. Debris was pelleted
(500Ug for 1 min), then mitochondria were isolated from the super-
natant (1 min 20 000Ug), suspended at 1^2 mg protein/ml in STE and
the supernatant retained as the cytoplasm. Protein concentrations
were determined using the bicinchoninic acid assay using BSA as a
standard [21]. About 33^40% of the activity of the matrix enzyme
citrate synthase [22] was recovered in the mitochondrial fraction,
and only 5^7% of the total lactate dehydrogenase activity [23]. For
alkali extraction, mitochondria were suspended in 50 Wl 100 mM
Na2CO3 and after 30 min incubation on ice, membranes were pelleted
by centrifugation (30 min at 100 000Ug) and proteins in the super-
natant acid precipitated. Protein samples were separated by SDS-
PAGE, transferred to nitrocellulose and blocked with 5% non-fat
milk powder in PBS. Blots were probed with a mouse monoclonal
antibody against the HA tag (12CA5, Babco, Richmond, CA, USA;
1:1000) and against human cytochrome oxidase, subunit 2 (12C4-F12,
Molecular Probes; 1:500). Blots were then incubated with rabbit anti-
serum raised against mouse IgG (M 7023, Sigma; 1:2000), followed
by incubation with [125I]protein A and bands were visualised by auto-
radiography.
2.5. Measurement of mitochondrial membrane potential
COS7 cells were transiently transfected with lipofectin/plasmid, or
mock-transfected with lipofectin alone. Cells were harvested, washed
in PBS and counted using a new improved Neubeyer haemocytome-
ter. Cells (500 000) were pelleted by centrifugation and resuspended in
1 ml DMEM containing glucose (4.5 g/l), 10 mM HEPES^NaOH, pH
7.4, 1 WM methyltriphenylphosphonium (TPMP), 500 nM sodium
tetraphenylboron and 100 nCi/ml [3H]TPMP and incubated for 1 h
at 37‡C. Cells were pelleted by centrifugation and the supernatant and
pellets separated and processed for scintillation counting [24]. TPMP
binding to deenergised cells was estimated from parallel incubations in
medium supplemented with 12.5 WM oligomycin, 20 WM carbonyl
cyanide-p-tri£uoromethoxyphenylhydrazone (FCCP), 1 WM myxo-
thiazol, 100 nM valinomycin and 1 mM ouabain. TPMP accumula-
tion was calculated by subtracting the amount of TPMP bound to
deenergised cells and is expressed as an accumulation ratio ((TPMP/
mg protein)/(TPMP/Wl supernatant)).
2.6. Import of UCP3S and UCP3L into isolated mitochondria
Yeast mitochondria (200 Wg protein) puri¢ed from lactate-grown
yeast [25] were incubated with radiolabelled UCP3L and UCP3S pro-
teins at 25‡C in 800 Wl import bu¡er (600 mM sorbitol, 50 mM
HEPES^KOH, pH 7, 50 mM KCl, 10 mM MgCl2, 2.5 mM EDTA,
2 mM KH2PO4, 1 mg/ml BSA and 0.75 mg/ml methionine) supple-
mented with 2 mM ATP and 2 mM NADH: for incubations without
membrane potential, 1 Wg/ml valinomycin was added [18]. Mitochon-
dria were then pelleted and resuspended in 200 Wl 0.6 M sorbitol,
20 mM HEPES^KOH, pH 7.4, supplemented with 50 Wg/ml trypsin
and after 30 min on ice, 200 Wg/ml soy bean trypsin inhibitor was
added and 5 min later, the mitochondria were pelleted. For osmotic
shock, mitochondria were suspended in 200 Wl 0.6 M sorbitol, 20 mM
HEPES^KOH, pH 7.4, and then diluted 10-fold in 20 mM HEPES^
KOH, pH 7.4, and after 30 min on ice, mitoplasts were isolated by
centrifugation and the supernatant protein was acid-precipitated. Liv-
er mitochondria were prepared from starved, female rats [26] and
protein was quantitated by the biuret method using BSA as a stand-
ard [27]. Mitochondria (300 Wg protein) were suspended at 30‡C in 40
Wl import bu¡er (220 mM mannitol, 70 mM sucrose, 10 mM HEPES^
KOH, 1 mM MgCl2, 1 mM EGTA, pH 7.6) supplemented with 1 mg/
ml BSA, 1 mM dithiothreitol, 10 mM K-succinate, 2 mM ATP, 0.1
mM GTP, 1.5 mM creatine phosphate and 15 Wg/ml creatine kinase
[28,29]. For incubations in the absence of a membrane potential,
oligomycin, antimycin and FCCP were added (5 WM of each). After
incubation, the mitochondria were pelleted and resuspended in 200 Wl
0.6 M sorbitol, 20 mM HEPES^KOH, pH 7.4, containing 200 Wg/ml
proteinase K for 30 min on ice, then 2 mM phenylmethyl sulfonyl
£uoride was added and 15 min later, mitochondria were pelleted. For
alkali extraction, mitochondria or mitoplasts were resuspended in 100
Wl 100 mM Na2CO3, incubated on ice for 30 min, the membranes
pelleted by centrifugation for 30 min at 100 000Ug and supernatant
protein acid-precipitated. All mitochondrial samples were separated
by SDS-PAGE electrophoresis and the 35S-labelled proteins visualised
by £uorography [18].
3. Results
3.1. Expression of UCP3S-HA and UCP3L-HA in mammalian
cells
To determine the locations of the two UCP3 isoforms with-
in mammalian cells, we incorporated HA tags and transiently
expressed the tagged proteins in COS7 cells (Fig. 1). Immuno-
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£uorescence microscopy showed that both UCP3L-HA and
UCP3S-HA colocalised with the mitochondrial marker Mito-
tracker (Fig. 1A). Cells transfected with the HA-tagged pro-
teins were subfractionated and immunoblotting with an anti-
HA antibody con¢rmed that most UCP3L-HA and UCP3S-
HA expressed in these cells was mitochondrial (Fig. 1B). Al-
kali extraction of these mitochondria with Na2CO3, which
leaves only integral membrane proteins [30], showed that
both UCP3L-HA and UCP3S-HA were found predominantly
in the membrane pellet, along with the mitochondrial inner
membrane protein cytochrome oxidase (Fig. 1B). Hence, both
UCP3S-HA and UCP3L-HA are integral, mitochondrial inner
membrane proteins.
The time courses of expression of UCP3L-HA and UCP3S-
HA in COS7 cells were determined (Fig. 2). From 12 to 36 h
after transfection, the speci¢c amounts of both UCP3-HA
isoforms in whole cells were similar (Fig. 2A, upper row).
When mitochondrial fractions were prepared from these cells,
the speci¢c amounts of the two isoforms in mitochondria were
also similar at each time point (Fig. 2A, lower row). Quanti-
¢cation of these expression levels in mitochondria by scanning
densitometry of autoradiographs (Fig. 2B) con¢rmed that the
speci¢c amounts of UCP3S and UCP3L in mitochondria were
similar at each time point. Therefore, both UCP3 isoforms
have similar time courses of expression and mitochondrial
localisation within cells.
3.2. E¡ect of UCP3S-HA and UCP3L-HA on mitochondrial
membrane potential
As the speci¢c amounts of the two isoforms within mito-
chondria were similar, we could compare their uncoupling
e⁄cacies by measuring the membrane potential at various
times after transfection. The membrane potential of cells
transfected with either UCP3L-HA or UCP3S-HA was meas-
ured and compared with that of mock-transfected cells (Fig.
3). At 18 h after transfection, neither UCP3 isoform a¡ected
membrane potential, but after 24^36 h, both isoforms de-
creased the membrane potential to similar extents (Fig. 3),
suggesting that both isoforms have similar e¡ects on the mem-
brane potential under these conditions.
3.3. Import of UCP3L and UCP3S into isolated mitochondria
To determine whether there were kinetic di¡erences in the
import of both isoforms of UCP3 into isolated mitochondria,
we translated UCP3L and UCP3S in vitro in a reticulocyte
lysate and incubated the radiolabelled proteins with isolated
mitochondria (Fig. 4). Both UCP3L and UCP3S were im-
ported into yeast mitochondria and became inaccessible to
added protease, indicating that they had been transported
across the mitochondrial outer membrane (Fig. 4A). To de-
termine their location within mitochondria, we disrupted the
outer membrane by osmotic shock, which released about 75%
of cytochrome b2 from the intermembrane space into the
Fig. 1. Mitochondrial localisation of UCP3L-HA and UCP3S-HA within cells. COS7 cells were transiently transfected with UCP3L-HA and
UCP3S-HA. In A, cells were incubated with Mitotracker before being ¢xed and immunostained with an antibody against HA tag which was
then linked to a FITC-conjugated antibody. Under £uorescent microscopy, the HA-tagged UCP3s are green, mitochondria are red and colocal-
ised HA-tagged UCPs and mitochondria appear yellow in digitally overlaid images. In B, cells were harvested 24 h after transfection and sepa-
rated into mitochondrial and cytoplasmic fractions. The mitochondria were further separated into integral membrane proteins (P) and other
proteins (S) by alkali extraction with Na2CO3. Protein (50 Wg) was separated by SDS-PAGE and immunoblotted with antibodies against the
HA tag or against cytochrome oxidase subunit 2 (Cox2) and visualised by decoration with [125I]protein A followed by autoradiography.
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supernatant but none of the matrix enzyme K-ketoglutarate
dehydrogenase (data not shown). In the presence of a mem-
brane potential, both UCP3 isoforms remained associated
with the mitoplast pellet (Fig. 4A). Alkali extraction of the
mitoplasts with Na2CO3 showed that both UCP3 isoforms
were inserted into the inner membrane in the presence of a
membrane potential (Fig. 4A). The amount of UCP3S in-
serted was less than UCP3L (Fig. 4A), so to analyse this
di¡erence, we measured the time courses of insertion of the
two proteins into the inner membrane (Fig. 4B). Aliquots
from the import reaction were removed at various times, pro-
tease-treated and then alkali-extracted (Fig. 4B). UCP3L was
rapidly inserted into the inner membrane over 10 min, but the
amount of UCP3S inserted into the membrane was signi¢-
cantly less (Fig. 4B). Quantitation of the autoradiographs
by scanning densitometry showed that the rate of insertion
of UCP3S was 50^80-fold slower than for UCP3L. This quan-
titative di¡erence may be due to importing mammalian pro-
teins into yeast mitochondria, therefore, we imported UCP3L
and UCP3S into rat liver mitochondria (Fig. 4C). After im-
port, the mitochondria were protease-treated and extracted
with alkali to leave only proteins that had inserted into the
membrane. Both UCP3L and UCP3S inserted into the inner
membrane of rat liver mitochondria in a potential dependent
Fig. 2. Time course of expression of UCP3s in cells. COS7 cells ex-
pressing UCPL-HA or UCPS-HA were isolated at various times
after transfection and a mitochondrial fraction was prepared. In A,
cell and mitochondrial protein (50 Wg) for each time point were sep-
arated by SDS-PAGE, immunoblotted with antibodies against the
HA tag and visualised by decoration with [125I]protein A followed
by autoradiography. This is a typical experiment that was repeated
three times. In B, the UCP3 contents of the mitochondrial fractions
in A were quantitated by scanning densitometry and plotted against
time, as a percentage of the expression at 36 h (UCP3L-HA, circles;
UCP3S-HA, squares).
Fig. 3. Mitochondrial membrane potential in cells expressing
UCP3L-HA and UCP3S-HA. Mock-transfected COS cells (squares)
and cells transfected with UCPL-HA (circles) or UCPS-HA (trian-
gles) were isolated at various times after transfection. The mitochon-
drial membrane potential was measured from the TPMP accumula-
tion ratio. Data are mean þ S.E.M. of experiments on three di¡erent
cell preparations.
Fig. 4. UCP3L and UCP3S import into isolated mitochondria. Ra-
diolabelled UCP3L and UCP3S were incubated with mitochondria
in the presence or absence of a membrane potential (v8). After im-
port, mitochondria were treated with protease to remove non-im-
ported precursor. All protein samples were separated by SDS-PAGE
and visualised by £uorography. Data shown are typical experiments
which were all repeated four or ¢ve times. ‘STD’ refers to a per-
centage of the radiolabelled precursor used in the import. In A,
UCP3L and UCP3S were imported into yeast mitochondria for
20 min (Mito). Mitoplasts were then prepared by osmotic shock (P)
and proteins remaining in the supernatant were acid-precipitated
(S). Mitoplasts were alkali-extracted with Na2CO3 and the mem-
brane pellets analysed. STD = 10%. In B, UCP3L and UCP3S were
imported into yeast mitochondria for various times, then alkali-ex-
tracted and the membrane pellets analysed. STD = 2.5%. In C,
UCP3L and UCP3S were imported into rat liver mitochondria for
various times and the membrane pellets after alkali extraction were
analysed. STD = 20%.
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fashion, however, the rate of insertion of UCP3S was still 10^
20-fold slower than for UCP3L (Fig. 4C). We conclude that
both UCP3 isoforms are imported into mitochondria and in-
serted into the inner membrane in vitro, but that UCP3S
inserts more slowly than UCP3L. Import into mitochondria
occurs without proteolytic processing as there was no size
di¡erence between the standards and imported proteins in
Fig. 4.
4. Discussion
We investigated possible mechanisms by which UCP3L
could favour fat oxidation over UCP3S in vivo. When
COS7 cells were transiently transfected with HA-tagged
UCP3L and UCP3S, both were found in mitochondria and
subfractionation of these mitochondria showed that they were
present in the inner membrane. Therefore, the absence of the
sixth membrane spanning domain in UCP3S does not prevent
its insertion into the mitochondrial inner membrane. The rates
of expression and insertion into mitochondria of the two iso-
forms within COS7 cells were similar and both isoforms de-
creased the membrane potential to the same extent. This sug-
gests that both UCP3 isoforms have similar mitochondrial
uncoupling activities, consistent with results obtained by ex-
pressing both UCP3 isoforms in yeast [10^12]. As no func-
tional or localisation di¡erences between the two isoforms
were found in cells, we investigated their kinetics of import
into isolated mitochondria in more detail. Both isoforms were
taken up by mitochondria in vitro and inserted into the inner
membrane in a membrane potential dependent fashion. This
occurred without proteolytic processing, indicating that tar-
geting information for both isoforms is present within the
mature protein, con¢rming that the sixth transmembrane do-
main is not essential for directing insertion of UCP3 into the
mitochondrial inner membrane. However, insertion of UCP3S
was signi¢cantly slower than that of UCP3L in both yeast and
rat liver mitochondria, suggesting that the sixth transmem-
brane domain does facilitate the incorporation of UCP3L
into the membrane. The slower membrane insertion of
UCP3S may contribute to the decreased fat oxidation and
increased obesity in subjects heterozygous for the mutation
that truncates UCP3L, leaving a protein the same size as
UCP3S [9].
Several questions remain. The sixth transmembrane domain
of UCP3L could act in other ways than through facilitating
protein insertion. In UCP1, binding of purine nucleotides to
this domain inhibits uncoupling and its absence from UCP3S
may enable both regulated and unregulated forms of UCP3 to
coexist [5]. However, the regulation of UCP3 may be quite
di¡erent from UCP1, and if UCP3L is inhibited by nucleo-
tides, then UCP3S should have the greater uncoupling activity
[31]. In COS7 cells, the UCP3 content may be greater than in
skeletal muscle, decreasing the membrane potential non-spe-
ci¢cally by disrupting the inner membrane. Possibly the two
UCP3 isoforms have quite di¡erent e¡ects on membrane po-
tential at the expression levels and regulatory environment
that occur in vivo, and the HA tag may also a¡ect UCP3
function. It is unclear why the dramatic di¡erence in the
rate of insertion into mitochondria found in vitro did not
a¡ect the relative steady state levels of the two UCP3 isoforms
in mitochondria within cells. We conclude that both the long
and short isoforms of UCP3 are imported into mitochondria
and inserted into the inner membrane where they have similar
e¡ects on the membrane potential. The only major di¡erence
between the two isoforms was that the rate of insertion into
isolated mitochondria of the short isoform was slower than
that of the long isoform.
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